“borderline significance”

The small hyperuricemic subgroup and the borderline significance observed in men ( P -value = .05) require careful interpretation.

The subgroup analysis “test protocols” showed a borderline significance for cycling tests for the comparison of CAF-BJ with PLA (SMD = 0.39, 95% CI [−0.00, 0.78], p = 0.05).

Furthermore, in the CMV group, CRP gained borderline significance in the regression models as an independent predictor ( p <0.05).

The benefit of prehabilitation appeared more pronounced, with borderline significance, in patients undergoing “other” (non-colorectal) surgeries (RR = 0.54, 95% CI 0.30 to 0.99, p=0.05) compared to those undergoing colorectal surgery (RR = 0.73, 95% CI 0.39 to 1.34, p=0.31).

After dividing the patients based on whether they were older than 50, the results showed borderline significance in older patients ( P =0.050).

The patient-reported ipsilateral VAS pain score was correlated with non-dominant knee medial compartment SBCs in borderline significance (r: 0.283, P: 0.051), but not with non-dominant lateral SBCs (P > 0.05).

Anxiety scores (HADS-Anxiety) showed a trend toward improvement in the intervention group, reaching borderline significance at T48 ( p = 0.05).

The OS in HCC patients with higher expression of Globo H (mean: 89.9, 95% CI: 77.3–102.5 months) was also shorter than those with lower expression of Globo H, albeit with borderline significance (mean: 112.3, 95% CI: 105.7–118.9 months; p = 0.05) [ Fig. 2 B].

However, when adjusting for covariates, none of the cohorts of interest were associated with having a statistically significant difference in ADL difficulty, although borderline significance was seen for having stage III/IV difficulty when comparing nAMD vs control (OR, 0.74; 95% CI, 0.54-1.00; P < .05) ( Figure 2 ).

28 The combined outcome of stroke, AMI, and/or death was 12%, showing statistically significant association with the PLR (p=0.03) and borderline significance with relation to the NLR (p=0.05).

Pain reduction, assessed by VAS scores, was significantly greater in the PRP group at 3 months (mean difference: −1.33, P < 0.01, I 2 = 38%) with borderline significance at 6 months (mean difference: −0.78, P = 0.05).

In addition, the effect of the group factor showed borderline significance (F=3.906, p=0.050, η 2 =0.032).

Mean vitamin A levels are reported to be lower in PwMS than in controls but with borderline significance ( P = 0.05) [ 114 ] .

Hepcidin levels were decreased after 12 weeks of roxadustat administration, with borderline significance in the entire cohort {140.2 ng/ml [interquartile range (IQR) 85.2–194.4] versus 110.5 ng/ml [IQR 46.1–167.1], P = .050} (Table 1 ).

It significantly outperformed two ocular oncology fellows ( p = 0.02 and 0.03, respectively) and demonstrated borderline significance compared to a senior ophthalmologist ( p = 0.05).

The near vergence facility test demonstrated a borderline significance value ( OR = 0.95, P = 0.05).

However, triglyceride levels showed borderline significance in the high MVPA/high SB group (OR, 0.71; 95% CI, 0.54–0.92; P <0.05).

There was no significant difference found for SBP ( p = 0.712) and borderline significance for the DBP ( p = 0.050) between the groups.

The tissue Doppler-derived E/A ratio showed only borderline significance between GRACE-defined risk groups (P=0.050).

The borderline significance was defined as the P ≥ 0.05, but < 0.10 (0.05 ≤ P < 0.10).

A negative correlation was observed for eHbA1c and total daily and mild hypoglycemic events (r=−0.57 and r=−0.66, respectively, p<0.0001), whereas for serious hypoglycemic events there was only a borderline significance (r=−0.13, p=0.05).

Variables with statistical significance ( p < 0.05) or borderline significance ( p = 0.05–0.10) in univariable analysis were included in the multivariate models.

Second, the small sample size (n = 8) and predominance of female patients limit statistical power for detecting small-to-moderate effects, increasing the likelihood of type II error for findings with borderline significance ( p = 0.050–0.058).

A subgroup analysis by treatment showed borderline significance between global QoL and mortality risk in both HSCT (HR: 1.05, 95% CI: 1.00–1.11, p = 0.05, I 2 = 0%) and chemotherapy (HR: 1.04, 95% CI: 1.00–1.09, p = 0.05, I 2 = 74%).

In the multivariable-adjusted analysis, sodium (adjusted odds ratio [OR] 0.89, 95% confidence interval [CI] 0.82–0.96; p = 0.004) and potassium (adjusted OR 0.87, 95% CI 0.77–0.99; p = 0.04) remained significantly associated, while phosphorus showed borderline significance (adjusted OR 0.64, 95% CI 0.41–1.00; p = 0.05).